Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • indian pharma news

    Tag: indian pharma news

    You Searched For "indian pharma news"
    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Alembic Pharma Q2 net rises over 1 percent to Rs 121 crore

    Ruby Khatun Khatun9 Nov 2017 10:16 AM IST
    New Delhi: Alembic Pharmaceuticals reported a 1.44 percent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended...
    To market new drugs in India, global trials must include Indians

    To market new drugs in India, global trials must include Indians

    Ruby Khatun Khatun12 Oct 2017 3:21 PM IST
    New Delhi: The drug regulator in a recent technical committee meeting, headed by Jagdish Prasad, Director General of Health Services, has made it...
    Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent

    Intas Pharma cuts down price of cancer drug Bevacizumab by 60 percent

    Ruby Khatun Khatun6 Oct 2017 11:12 AM IST
    AHMEDABAD: Intas Pharmaceuticals Limited, announced that the company is cutting down the cost of the cancer drug Bevacizumab by 60 percent in order to...
    Zydus gets USFDA nod for overactive bladder drug

    Zydus gets USFDA nod for overactive bladder drug

    Ruby Khatun Khatun6 Oct 2017 9:49 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
    Cigna to end OxyContin painkiller coverage, signs contract for alternative

    Cigna to end OxyContin painkiller coverage, signs contract for alternative

    Ruby Khatun Khatun6 Oct 2017 9:30 AM IST
    Amid a growing U.S. opioid addiction, health insurer Cigna Corp will stop covering OxyContin, the opioid painkiller sold by Purdue Pharma LP, as of...
    Integra LifeScience acquires codman neurosurgery business from Johnson and Johnson

    Integra LifeScience acquires codman neurosurgery business from Johnson and Johnson

    Ruby Khatun Khatun6 Oct 2017 9:15 AM IST
    PLAINSBORO, N.J.: Integra LifeSciences Holdings Corporation, a global leader in medical technology, announced that it has completed the previously...
    Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar

    Fosun Pharma acquires 74 percent stake in Gland Pharma for 1.09 billion dollar

    Ruby Khatun Khatun5 Oct 2017 10:53 AM IST
    New Delhi: Chinese drug firm Fosun Pharma has acquired approximately 74 percent in Hyderabad-based Gland Pharma at a valuation of not more than USD...
    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Zydus gets USFDA nod to market anti-diuretic nasal spray

    Ruby Khatun Khatun5 Oct 2017 10:17 AM IST
    New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
    Police raid French HQ of pharma giant Merck

    Police raid French HQ of pharma giant Merck

    Ruby Khatun Khatun5 Oct 2017 9:49 AM IST
    Paris: Police on Tuesday raided the French headquarters of German pharmaceutical giant Merck, the maker of a thyroid drug at the center of a medical...
    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Ruby Khatun Khatun4 Oct 2017 10:55 AM IST
    New Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
    Merck to stop development of hepatitis C treatments

    Merck to stop development of hepatitis C treatments

    Ruby Khatun Khatun4 Oct 2017 10:20 AM IST
    U.S. drugmaker Merck & Co said on Friday it would discontinue developing an experimental drug combination for chronic hepatitis C, as competition...
    VLCC acquires nutraceutical maker Wellscience

    VLCC acquires nutraceutical maker Wellscience

    Ruby Khatun Khatun31 May 2017 11:41 AM IST
    New Delhi: Beauty and wellness firm VLCC said it has acquired nutraceutical products maker Wellscience that would enable entry into the new...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok